Results 291 to 300 of about 2,734,758 (393)

Non-Invasive Biomarkers and Breath Tests for Diagnosis and Monitoring of Chronic Liver Diseases. [PDF]

Diagnostics (Basel)
Boon-Yasidhi P, Karnsakul W.
europepmc   +1 more source

Anaemia in chronic liver disease

, 1964
Carlien L. Kimber
openalex   +1 more source

Expert consensus on clinical usefulness of M2BPGi for managing chronic liver diseases

Tai‐Chung Tseng, Yao‐Chun Hsu, Tung‐Hung Su, Chen‐Hua Liu, Chia‐Chi Wang, Chih‐Lin Lin, Hwai‐I Yang, Yi‐Hsiang Huang, Sheng‐Shun Yang, Cheng‐Yuan Peng, Tsung‐Hui Hu, Jee‐Fu Huang, Jia‐Horng Kao   +12 more
openalex   +1 more source

DENTA: A Dual Enzymatic Nanoagent for Self‐Activating Tooth Whitening and Biofilm Disruption

Advanced Functional Materials, EarlyView.
The nanoapatite with dual enzymes (DENTA) accumulates in dentinal tubules, reducing hypersensitivity caused by dental nerve exposure and facilitating continuous ROS generation through salivary glucose for effective, long‐term whitening. The dentin structures remain non‐destructive due to the low concentration of ROS, demonstrating excellent cell ...
Junseok Kim, Dai‐Hwan Kim, Priyannth R. Sundharbaabu, Chae Yeon Lee, Jina Bae, Jiyu Hyun, Young‐Ju Jang, Haeni Kim, Min‐Ho Hong, Juewen Liu, Tobias Fey, Suk Ho Bhang, Jun Hyuk Heo, Jung Heon Lee   +13 more
wiley   +1 more source

Impact of myokines on chronic liver diseases: exploring the effects of metabolic dysfunction-associated steatotic liver disease (MASLD) on skeletal muscle. A narrative review. [PDF]

Eur J Transl Myol
Aguirre F, Valero-Breton M, Cabrera D, Peñailillo L, Otero MC, Fredes C, Cabello-Verrugio C.   +6 more
europepmc   +1 more source

Host‐Directed Biomaterials for Combatting Bloodstream Infections: From Macrocyclic Peptides to Immune‐Activating Cell Backpacks

Advanced Functional Materials, EarlyView.
Bloodstream infections (BSI) are one of the leading causes of mortality and morbidity in both civilian and military populations. This paper summarizes recent progress in novel treatment strategies to manage BSI arising from both bacterial and fungal pathogens using molecules, particles, and materials to elicit host‐directed immunity.
Thomas Thomou, Jagadish Krishnappa, Justin B. Schaal, Prasad Tongaonkar, Dat Q. Tran, Wenchao Gu, Yung‐Fu Chang, Michael E. Selsted, Shaoyi Jiang, Samir Mitragotri, Michael Super, Christopher J. Bettinger   +11 more
wiley   +1 more source

Bergamot Leaf Extract as an Agent Against Chronic Liver Diseases? In Vitro and In Vivo Findings on Oxidative Stress Modulation. [PDF]

Antioxidants (Basel)
Vieira TA, Seloto DG, Rizzi JS, Peixoto PVL, Corrêa GVB, Siqueira JS, Grandini NA, Nakandakare-Maia ET, Valente LC, Francisqueti-Ferron FV, Ferron AJT, Baron G, Aldini G, Correa CR, Pereira LC, Romualdo GR.   +15 more
europepmc   +1 more source

Implementation of Drug‐Induced Rhabdomyolysis and Acute Kidney Injury in Microphysiological System

Advanced Functional Materials, EarlyView.
A modular Muscle–Kidney proximal tubule‐on‐a‐chip integrates 3D skeletal muscle and renal proximal tubule tissues to model drug‐induced rhabdomyolysis and acute kidney injury. The coculture system enables dynamic tissue interaction, functional contraction monitoring, and quantification of nephrotoxicity, revealing drug side effect‐induced metabolic ...
Jaesang Kim, Zhuo Feng Lee, Gi‐Dong Sim, Sejoong Kim, Jessie S. Jeon   +4 more
wiley   +1 more source

Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions. [PDF]

Theranostics
Yan M, Cui Y, Xiang Q.
europepmc   +1 more source

Iron and Chronic Liver Disease

Journal of the Royal College of Physicians of London, 1973
openaire   +2 more sources